Interaction of High- and Low-Risk Human Papillomavirus Genotypes is Associated with a Reduced Risk of Developing Cervical Cancer

Malihe Hasanzadeh,Marzieh Rejali,Ghazaleh Khalili-Tanha,Mehraneh Mehramiz,Negar Yavari,Elham Nazari,Parnian Malakuti,Faezeh Maleki,Ghazale Ghorbannezhad,Mahdi Rafiei,Anahita Mirani,Negar Gholampoor-Shamkani,Hoda Saber,Leila Mousavi Seresht,Zohreh Emamdadi-Aliabad,Zahra Mahdian,Mahdieh Akbari,Gordon A Ferns,Ala-Eddin Al Moustafa,Amir Avan
DOI: https://doi.org/10.2174/0118715265307980240826060516
2024-09-20
Abstract:Introduction: Cervical cancer is among the most common types of cancer in women and is associated with human papillomavirus (HPV) infection. The association between cervical cancer and high-risk HPV infection has been well documented. However, the effect of simultaneous infection with high- and low-risk HPV or low-risk HPV alone on the risk of developing cervical malignancy remains unanswered in guidelines. Method: We investigated the association of high and low-risk HPVs (HR or LR) genotypes with cervical carcinoma risk and pathological and cytological information in cases recruited from a population-based cohort study of 790 patients. Correlation matrix and t-test were used for analysis. Results: The percentage of HR+LR and HR-HPV16/18 were 9.30% and 11.20% in class II, 7.15% and 7.10% in class IV, and 7.15% and 5.80% in As-CUS smears. Interestingly, concurrent infection with HR-HPV and LR-HPV types led to a significant reduction in the risk of developing malignancy compared to the high-risk group (OR=0.3 (0.098-0.925), pvalue=0.04). The percentage of individuals with cervical malignancy was 10.2% and 28.2% within the co-infected and the HR-HPV participants. Conclusion: Our findings suggest that simultaneous infection with high- and low-risk HPV may reduce the risk of cervical malignancy.
What problem does this paper attempt to address?